GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » DaVita Inc (STU:TRL) » Definitions » Cyclically Adjusted Revenue per Share

DaVita (STU:TRL) Cyclically Adjusted Revenue per Share : €90.50 (As of Mar. 2024)


View and export this data going back to 1995. Start your Free Trial

What is DaVita Cyclically Adjusted Revenue per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

DaVita's adjusted revenue per share for the three months ended in Mar. 2024 was €31.198. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is €90.50 for the trailing ten years ended in Mar. 2024.

During the past 12 months, DaVita's average Cyclically Adjusted Revenue Growth Rate was 10.30% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was 14.30% per year. During the past 5 years, the average Cyclically Adjusted Revenue Growth Rate was 13.50% per year. During the past 10 years, the average Cyclically Adjusted Revenue Growth Rate was 11.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of DaVita was 24.40% per year. The lowest was 9.30% per year. And the median was 14.80% per year.

As of today (2024-05-24), DaVita's current stock price is €121.60. DaVita's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2024 was €90.50. DaVita's Cyclically Adjusted PS Ratio of today is 1.34.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of DaVita was 2.33. The lowest was 0.78. And the median was 1.47.


DaVita Cyclically Adjusted Revenue per Share Historical Data

The historical data trend for DaVita's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

DaVita Cyclically Adjusted Revenue per Share Chart

DaVita Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 50.45 51.10 65.41 81.32 85.11

DaVita Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 82.03 83.85 90.12 85.11 90.50

Competitive Comparison of DaVita's Cyclically Adjusted Revenue per Share

For the Medical Care Facilities subindustry, DaVita's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


DaVita's Cyclically Adjusted PS Ratio Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, DaVita's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where DaVita's Cyclically Adjusted PS Ratio falls into.



DaVita Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, DaVita's adjusted Revenue per Share data for the three months ended in Mar. 2024 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=31.198/131.7762*131.7762
=31.198

Current CPI (Mar. 2024) = 131.7762.

DaVita Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201406 10.774 100.560 14.119
201409 11.616 100.428 15.242
201412 12.402 99.070 16.496
201503 14.237 99.621 18.832
201506 14.063 100.684 18.406
201509 14.497 100.392 19.029
201512 -1.148 99.792 -1.516
201603 15.466 100.470 20.285
201606 15.904 101.688 20.610
201609 16.061 101.861 20.778
201612 13.007 101.863 16.827
201703 12.598 102.862 16.139
201706 12.385 103.349 15.792
201709 12.120 104.136 15.337
201712 12.714 104.011 16.108
201803 12.709 105.290 15.906
201806 14.194 106.317 17.593
201809 14.589 106.507 18.050
201812 14.901 105.998 18.525
201903 14.556 107.251 17.885
201906 15.083 108.070 18.392
201909 17.429 108.329 21.201
201912 20.015 108.420 24.327
202003 20.263 108.902 24.519
202006 20.613 108.767 24.974
202009 20.028 109.815 24.033
202012 20.639 109.897 24.748
202103 20.806 111.754 24.534
202106 21.725 114.631 24.974
202109 22.739 115.734 25.891
202112 24.862 117.630 27.852
202203 25.455 121.301 27.653
202206 28.318 125.017 29.849
202209 31.933 125.227 33.603
202212 29.970 125.222 31.539
202303 29.012 127.348 30.021
202306 29.645 128.729 30.347
202309 31.100 129.860 31.559
202312 31.092 129.419 31.658
202403 31.198 131.776 31.198

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.


DaVita  (STU:TRL) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

DaVita's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=121.60/90.5
=1.34

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of DaVita was 2.33. The lowest was 0.78. And the median was 1.47.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


DaVita Cyclically Adjusted Revenue per Share Related Terms

Thank you for viewing the detailed overview of DaVita's Cyclically Adjusted Revenue per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


DaVita (STU:TRL) Business Description

Industry
Traded in Other Exchanges
Address
2000 16th Street, Denver, CO, USA, 80202
DaVita is the largest provider of dialysis services in the United States, boasting market share that eclipses 35% when measured by both patients and clinics. The firm operates over 3,000 facilities worldwide, mostly in the U.S., and treats over 240,000 patients globally each year. Government payers dominate U.S. dialysis reimbursement. DaVita receives about two thirds of U.S. sales at government (primarily Medicare) reimbursement rates, with the remainder coming from commercial insurers. However, while commercial insurers represented only about 10% of the U.S. patients treated, they represent nearly all of the profits generated by DaVita in the U.S. dialysis business.

DaVita (STU:TRL) Headlines

No Headlines